Teleflex (TFX)
(Delayed Data from NYSE)
$211.44 USD
+0.19 (0.09%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $211.69 +0.25 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Brokerage Reports
Teleflex Incorporated [TFX]
Reports for Purchase
Showing records 421 - 440 ( 470 total )
Company: Teleflex Incorporated
Industry: Medical - Instruments
Growth and Margin Expectations Appear More Muted NT; Lowering Estimates
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Reduced Sales Guidance and Changes to Restructuring Actions Likely to Offset EPS Positives
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Benefits of Gross Margin Initiatives Evident and Driving EPS Leverage
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Similar to Peers, Solid Quarter and Modest Bump to EPS Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Valuation Still Matters; Downgrade to SW
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Raising Estimates and PT, but Still See Incremental Upside to our Model
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Results a Modest Positive, but Expectations Were Raised Given Competitive Reports
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: Takeaways from SAGES Meetings; Incrementally Positive on TFX - HRC
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Organic Growth and Margin Trajectory Strengthening into 2016; Raise PT to $159
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: 4Q Earnings Preview; Results Likely in Line; Cautious Around 2016 Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
2016 KBCM Healthcare Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Initial Results from the Cleveland Clinic on Percuvance Now Available
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Impact of Potential Government Spending Agreement on Medical Products/Life Science Tools Coverage
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
A Minimally Invasive Path to Organic Growth; Raising Awareness Ahead of 1Q16 Commercial Launch
Provider: KEYBANC CAPITAL MARKETS